The Development and Optimization of Diagnostic Assays is at the Heart of MolecularMD's Business Model. MMD Prepares the Assay for Fitness in a Clinical Trial, or for the Added Rigor of Design Control Documentation, Aligning with Regulatory Requirements for the Future Designation as a Companion Diagnostic.
Our role is to assist our clients in accelerating the approval of precision medicines in Oncology. The majority of our projects require a customized approach for assay development and validation. However, as an outcome of multiple requests, MolecularMD has validated a growing group of assays which are in stock and ready for use. We are always prepared to discuss your specific, custom requirements as this is where we spend a majority of our focus and energy.